Associations Between Multimorbidity and Cerebrospinal Fluid Amyloid: A Cross-Sectional Analysis of the European Prevention of Alzheimer’s Dementia (EPAD) V500.0 Cohort

Multimorbidity and quality of life: systematic literature review and meta-analysis

(2019) Tatjana T. Makovski et al.   AGEING RESEARCH REVIEWS

Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort

(2019) Bhautesh Dinesh Jani et al.   BMC Medicine

Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging

(2018) Suzanne E. Schindler et al.   Alzheimers & Dementia

CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts

(2018) Oskar Hansson et al.   Alzheimers & Dementia

The National Institute on Aging—Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials

(2018) Jeffrey Cummings   Alzheimers & Dementia

Multimorbidity Is Associated with Preclinical Alzheimer’s Disease Neuroimaging Biomarkers

(2018) Aline Mendes et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

The Association of Multimorbidity With Preclinical AD Stages and SNAP in Cognitively Unimpaired Persons

(2018) Maria Vassilaki et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Hypertension and obesity moderate the relationship between β-amyloid and cognitive decline in midlife

(2018) Lindsay R. Clark et al.   Alzheimers & Dementia

European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol

(2018) Alina Solomon et al.   BMJ Open

A Systematic Review of Cost-of-Illness Studies of Multimorbidity

(2017) Lili Wang et al.   Applied Health Economics and Health Policy

Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid

(2016) Tobias Bittner et al.   Alzheimers & Dementia

Multimorbidity and neuroimaging biomarkers among cognitively normal persons

(2016) Maria Vassilaki et al.   NEUROLOGY

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

(2016) Clifford R. Jack et al.   NEUROLOGY

Exclusion of patients with concomitant chronic conditions in ongoing randomised controlled trials targeting 10 common chronic conditions and registered at ClinicalTrials.gov: a systematic review of registration details

(2016) Céline Buffel du Vaure et al.   BMJ Open

Multimorbidity and Risk of Mild Cognitive Impairment

(2015) Maria Vassilaki et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Reducing complexity: a visualisation of multimorbidity by combining disease clusters and triads

(2015) Ingmar Schäfer et al.   BMC PUBLIC HEALTH

Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden

(2014) Katie I Gallacher et al.   BMC Medicine

Chronic multisite pain in major depression and bipolar disorder: cross-sectional study of 149,611 participants in UK Biobank

(2014) Barbara I Nicholl et al.   BMC Psychiatry

Prevalence of polypharmacy in a Scottish primary care population

(2014) R. A. Payne et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later

(2013) C. M. Roe et al.   NEUROLOGY

Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults

(2013) D. A. Nation et al.   NEUROLOGY

Evidence for impaired amyloid β clearance in Alzheimer's disease

(2013) Kristin R Wildsmith et al.   Alzheimers Research & Therapy

A Systematic Review of Prevalence Studies on Multimorbidity: Toward a More Uniform Methodology

(2012) M. Fortin et al.   ANNALS OF FAMILY MEDICINE

Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study

(2012) Karen Barnett et al.   LANCET